Medical devices, healthcare technology and the business of care
510(k) clearance · K251558

Precision AI Surgical Planning System (PAI-SPS)

Precision AI Pty, Ltd. · Decision date Jan 12, 2026

FDA DECISIONK251558

What did the FDA decide?

FDA records K251558 as a 510(k) premarket notification, with a decision dated Jan 12, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Jan 12, 2026

FDA source record

Regulatory record facts

Identifier
K251558
Regulatory pathway
510(k) premarket notification
Product code
QHE
Decision code
SESE
Decision date
Jan 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Shoulder Arthroplasty Implantation System.

Product code
QHE
FDA device class
2

FDA decision timeline

  1. K251558 received

    Application receipt date recorded by FDA.

  2. K251558 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QHE

Product / regulatory recordCompanyPathwayDecision dateSource
Materialise NV510(k) clearanceJun 9, 2026FDA
Orthosoft Inc. (d/b/a) Zimmer CAS510(k) clearanceJun 4, 2026FDA
Orthosoft Inc. (d/b/a) Zimmer CAS510(k) clearanceFeb 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Precision AI Pty, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Fortitude Valley

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records